Steven R. Feldman, M.D., Ph.D.
Center for Integrative Medicine
Social Sciences & Health Policy
drugs/therapeutic agents pharm, education/training (all f, t,, epidemiology, health services, research/outc, hypertension, immunology/allergy/inflammatio, medical technology/devices
Academic: 336-716-7740 | Department: 336-716-3926
Media Medical Expert »
Farhangian ME, Snyder A, Huang KE, Doerfler L, Huang WW, Feldman SR. Cutaneous cryosurgery in the United States. J Dermatolog Treat. 2016;27(1):91-94.
Vaidya TS, Lewallen RS, Feldman SR. Erythrodermic psoriasis and severe hypotension requiring intensive care unit hospitalization: poor treatment outcome as a result of poor adherence. J Dermatolog Treat. 2016;27(2):134-135.
Hester C, Park C, Chung J, Balkrishnan R, Feldman S, Chang J. Medication adherence in children and adolescents with acne vulgaris in Medicaid: a retrospective study analysis. Pediatr Dermatol. 2016;33(1):49-55.
Hill D, Feldman SR. Online reviews of physicians: valuable feedback, valuable advertising [editorial]. JAMA Dermatol. 2016;152(2):143-144.
Smith JA, Narahari S, Hill D, Feldman SR. Tazarotene foam, 0.1%, for the treatment of acne. Expert Opin Drug Saf. 2016;15(1):99-103.
Taheri A, Mansoori P, Bahrami N, Alinia H, Watkins CE, Feldman SR. How frequency of electrosurgical current and electrode size affect the depth of electrocoagulation. Dermatol Surg. 2016;42(2):197-202.
Alinia H, Moradi Tuchayi S, Farhangian ME, Huang KE, Taylor SL, Kuo S, Richardson I, Feldman SR. Rosacea patients seeking advice: qualitative analysis of patients' posts on a rosacea support forum [editorial]. J Dermatolog Treat. 2016;27(2):99-102.
Korman AM, Hill D, Alikhan A, Feldman SR. Oral tofacitinib for the treatment of adults with moderate to severe chronic plaque psoriasis. Expert Rev Clin Pharmacol. 2016;():.
Papp KA, Krueger JG, Feldman SR, Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan H, Luo Y, Gupta P, Mallbris L,Tatulych S. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study. J Am Acad Dermatol. 2016;74(5):841-850.
Mudigonda T, Kaufman W, Feldman SR. Horrendous, treatment-resistant pediatric atopic dermatitis solved with a change in vehicle. J Drugs Dermatol. 2016;15(1):114-115.
Feldman SR. Advances in and hope for the treatment of parasitosis [editorial]. J Dermatolog Treat. 2016;27(3):197.
Huang WW, Feldman SR. The cost of applying to dermatology residency [editorial commentary]. J Am Acad Dermatol. 2016;74(4):775-776.
Korman AM, Hill D, Alikhan A, Feldman SR. Impact and management of depression in psoriasis patients [editorial]. Expert Opin Pharmacother. 2016;17(2):147-152.
Hill D, Feldman SR. Online reviews of physicians [reply to letter]. JAMA Dermatol. 2016;152(3):350-351.
Sandoval LF, Pierce A, Davis SA, Feldman SR. Improved psoriasis with weight loss: the role of behavioural factors [letter]. Br J Dermatol. 2015;172(3):826-827.
DeFilippis EM, Feldman SR, Huang WW. The genetics of pyoderma gangrenosum and implications for treatment: a systematic review. Br J Dermatol. 2015;172(6):1487-1497.
Taheri A, Mansoori P, Huang KE, Feldman SR. Effect of frequency on entrance and propagation pattern of high-frequency (radiofrequency) electrical currents in biologic tissues. Skin Res Technol. 2015;21(3):291-294.
Taheri A, Moradi Tuchayi S, Alinia H, Orscheln CS, Mansoori P, Feldman SR. Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: a retrospective study. J Dermatolog Treat. 2015;26(4):361-364.
Aslam I, Fleischer A, Feldman S. Emerging drugs for the treatment of acne. Expert Opin Emerg Drugs. 2015;20(1):91-101.
Vaidya T, Feldman SR, Kirk J. Patient-centered approach to biologics in the treatment of psoriasis. J Nat Sci. 2015;1(3):e53.
Kuo S, Huang KE, Davis SA, Feldman SR. The rosacea patient journey: a novel approach to conceptualizing patient experiences. Cutis. 2015;95(1):37-43.
Reeder VJ, Gustafson CJ, Mireku K, Davis SA, Feldman SR, Pearce DJ. Trends in mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg. 2015;41(3):397-403.
Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of primary nonadherence to acne treatment. JAMA Dermatol. 2015;151(6):623-626.
Anderson KL, Feldman SR. A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles. J Am Acad Dermatol. 2015;72(5):868-878.e1.
Anderson KL, Feldman SR. Reasons for treatment changes in patients with moderate to severe psoriasis. J Cutan Med Surg. 2015;19(4):361-366.
Davis SA, Huang KE, Feldman SR, Fleischer AB Jr, Huang WW. Trends in ambulatory health care usage for adult acne. J Cutan Med Surg. 2015;19(4):377-379.
Gerard AJ, Feldman SR, Strowd L. Quality of life of patients with pyoderma gangrenosum and hidradenitis suppurativa. J Cutan Med Surg. 2015;19(4):391-396.
Hopkinson D, Moradi Tuchayi S, Alinia H, Feldman SR. Assessment of rosacea severity: a review of evaluation methods used in clinical trials. J Am Acad Dermatol. 2015;73(1):138-143.e4.
Moustafa F, Hopkinson D, Huang KE, Feldman S. Prevalence of rosacea in community settings. J Cutan Med Surg. 2015;19(2):149-152.
Radack KP, Farhangian ME, Anderson KL, Feldman SR. A review of the use of tanning beds as a dermatological treatment. Dermatol Ther. 2015;5():37-51.
Farhangian ME, Huang WW, Feldman SR. Adherence to oral and topical medications in cutaneous lupus erythematosus is not well characterized. Dermatol Ther. 2015;5(2):91-105.
Hoffman MB, Farhangian M, Feldman SR. Psoriasis during pregnancy: characteristics and important management recommendations. Expert Rev Clin Immunol. 2015;11(6):709-720.
Langley RG, Feldman SR, Nyirady J, van de Kerkhof P, Papavassilis C. The 5-point Investigator's Global Assessment (IGA) scale: a modified tool for evaluating plaque psoriasis severity in clinical trials. J Dermatolog Treat. 2015;26(1):23-31.
Lin HC, Hunnicutt JN, Moustafa FA, Rohr AL, Huang KE, Balkrishnan R, Feldman SR. Pharmacological treatments in pregnant women with psoriasis in the U.S.A. [letter]. Br J Dermatol. 2015;172(3):807-810.
Alinia H, Feldman SR. Oral tofacitinib for psoriasis: what happens with interrupted treatment? [commentary]. Br J Dermatol. 2015;172(5):1194-1195.
Farhangian ME, Feldman SR. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate. Am J Clin Dermatol. 2015;16(4):285-294.
Farhangian ME, Feldman SR. Moving away from fee-for-service: implications for medication adherence. South Med J. 2015;108(5):298-299.
Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151(10):1081-1086.
Ali ST, Alinia H, Feldman SR. The treatment of rosacea with topical ivermectin. Drugs Today (Barc). 2015;51(4):243-250.
Armstrong AW, Feldman SR, Korman NJ, Meng X, Guana A, Nyirady J, Herrera V, Zhao Y. Efficacy of secukinumab in patients with plaque psoriasis: area under the curve of treatment reponse rates [abstract]. Value Health. 2015;18(3):A179.
Aslam I, Feldman SR. Practical strategies to improve patient adherence to treatment regimens. South Med J. 2015;108(6):325-331.
Feldman SR. Inflammatory diseases: integrating biosimilars into clinical practice. Semin Arthritis Rheum. 2015;44(6 Suppl):S16-S21.
Feldman SR, Herrera V, Zhao Y, Shi L. Timing of first-time use of biologics and healthcare costs and utilization in psoriasis [abstract]. Value Health. 2015;18(3):A296.
Feldman SR, Princic N, Zhao Y, Barghout V, Willson T, Song X, Guana A, Herrera V. Mortality risk in patients with psoriasis [abstract]. Value Health. 2015;18(3):A294.
Feldman SR, Zhao Y, Shi L, Tran MH, Lu J. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Arthritis Care Res (Hoboken). 2015;67(5):708-717.
Taheri A, Davis SA, Huang KE, Feldman SR. Onychomycosis treatment in the United States. Cutis. 2015;95(5):E15-E21.
Aslam I, Davis SA, Feldman SR, Martin WE. A review of patient lifting interventions to reduce health care worker injuries. Workplace Health Saf. 2015;63(6):267-275.
Bass AM, Farhangian ME, Feldman SR. Internet-based adherence interventions for treatment of chronic disorders in adolescents. Adolesc Health Med Ther. 2015;6():91-99.
Culp L, Moradi Tuchayi S, Alinia H, Feldman SR. Tolerability of topical retinoids: are there clinically meaningful differences among topical retinoids?. J Cutan Med Surg. 2015;19(6):530-538.
Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, Gupta P, Proulx J, Lan S, Wolk R. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials. Br J Dermatol. 2015;173(4):949-961.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.